Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: hilm who wrote (4710)	8/3/1998 3:51:00 AM
From: flickerful	Respond to of 9523

thanks hilm.... aaah, vasomax. they inflated the 60%, though it isn't exactly a number to promote. i wasn't sure if it had been discussed... so, i appreciate your input; what i find most annoying is an almost pathological focus on viagra related "news". the substance is irrelevant: frivolous litigation, wild reports of sexual predators, or as here, the alternative viagra... the point is to ride the hype.... it's more than overdone, it's shameless.

To: hilm who wrote (4710)	8/8/1998 1:25:00 AM
From: flickerful	Read Replies (2) \| Respond to of 9523

NEW DRUG MAY COMPETE WITH VIAGRA Saturday, August 08, 1998 Viagra, the fastest selling new drug in history, won't have the market to itself forever. Texas-based Zonagen Inc., announced it has asked the FDA for approval to sell its own product, Vasomax. The treatment for male erectile dysfunction is already sold in Mexico under the name Z-max. Like Viagra, Vasomax enhances the blood flow to the penis. Other drug companies are also rushing to get similar products to market. A joint venture between Takeda Chemical Industries of Japan and Abbott Laboratories, is working to develop a Parkinson's drug, apomorphine, as an erectile dysfunction drug. lycos.com